超声医学在甲状腺微小乳头状癌诊疗方面的研究进展
DOI:
CSTR:
作者:
作者单位:

1.甘肃中医药大学;2.甘肃省人民医院

作者简介:

通讯作者:

中图分类号:

基金项目:


Research progress of ultrasound medicine in the diagnosis and treatment of papillary thyroid microcarcinoma
Author:
Affiliation:

Gansu University Traditional Chinese Medicine

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    随着甲状腺微小乳头状癌(papillary thyroid microcarcinoma,PTMC)发病率的增加,对其研究也成为全球关注的热点。目前,PTMC的检出主要依靠多普勒超声和超声引导下细针穿刺细胞学检查,为了提高PTMC的诊断准确率,超声造影及弹性成像也被研究并应用。虽PTMC预后良好,但由于其肿瘤体积小,发病隐匿,导致其诊断仍存在一定程度的漏诊和误诊,且PTMC患者仍有局部复发及淋巴结转移的风险,因此,PTMC患者是否应立即行手术切除治疗或手术切除是否应加扫中央淋巴结成为其治疗的争议所在。故评估PTMC患者是否有淋巴结转移对其治疗有指导性价值,可避免其过度治疗。本文就超声医学在PTMC诊疗方面的研究进展进行阐述。

    Abstract:

    With the increase in the incidence of papillary thyroid microcarcinoma (PTMC), its research has become a global hotspot. At present, the detection of PTMC mainly relies on Doppler ultrasound and ultrasound-guided fine needle aspiration cytology. In order to improve the diagnostic accuracy of PTMC, contrast-enhanced ultrasound and elastography have also been studied and applied. Although PTMC has a good prognosis, its small tumor size and occult onset make a certain degree of missed diagnosis and misdiagnosis, and patients with PTMC still have a risk of local recurrence and lymph node metastasis. Therefore, Whether PTMC patients should be treated immediately by surgical resection and surgical resection should be added to the central lymph node are the controversy in its treatment. Therefore, evaluating whether PTMC patients have lymph node metastasis has a guiding value for their treatment and can avoid over-treatment.This article describes the research progress of ultrasound medicine in the diagnosis and treatment of PTMC.

    参考文献
    相似文献
    引证文献
引用本文

慈霞,周祖邦.超声医学在甲状腺微小乳头状癌诊疗方面的研究进展[J].临床超声医学杂志,2019,21(1):

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2018-07-23
  • 最后修改日期:2018-07-23
  • 录用日期:2018-08-03
  • 在线发布日期: 2019-01-28
  • 出版日期:
文章二维码

扫码关注

官方微信